{"DataElement":{"publicId":"3854782","version":"1","preferredName":"HMG-CoA Reductase Inhibitor Fulfill Low Density Lipoprotein Criterion Requirement Yes No Indicator","preferredDefinition":"The yes/no response regarding the requirement for administration of or increase in dosage of statins to meet low density lipoprotein (LDL) protocol goals.","longName":"3854781v1.0:3506068v1.0","context":"LCC","contextVersion":"1","DataElementConcept":{"publicId":"3854781","version":"1","preferredName":"HMG-CoA Reductase Inhibitor Fulfill Low Density Lipoprotein Criterion Requirement","preferredDefinition":"Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis._Satisfy the requirements or expectations of._Low-density lipoprotein (LDL) is a lipoprotein that carries cholesterol around the body, for use by various cells.  LDL transports cholesterol to the arteries and increased levels are associated with atherosclerosis, and thus myocardial infarctions and strokes. This is why cholesterol inside LDL lipoproteins is called bad cholesterol. (from Wikipedia)_Criteria; a basis for comparison; a reference point against which other things can be evaluated._Requirement; something that is necessary.","longName":"2480490v1.0:3854779v1.0","context":"LCC","contextVersion":"1","ObjectClass":{"publicId":"2480490","version":"1","preferredName":"HMG-CoA Reductase Inhibitor","preferredDefinition":"Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.","longName":"C1655","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HMG-CoA Reductase Inhibitor","conceptCode":"C1655","definition":"Any substance that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis. Inhibition of HMG-CoA reductase acts to lower plasma cholesterol and lipoprotein levels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12F9D0A0-985A-3DAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-04","modifiedBy":"ONEDATA","dateModified":"2006-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3854779","version":"1","preferredName":"Fulfill Low Density Lipoprotein Criterion Requirement","preferredDefinition":"Satisfy the requirements or expectations of.:Low-density lipoprotein (LDL) is a lipoprotein that carries cholesterol around the body, for use by various cells.  LDL transports cholesterol to the arteries and increased levels are associated with atherosclerosis, and thus myocardial infarctions and strokes. This is why cholesterol inside LDL lipoproteins is called bad cholesterol. (from Wikipedia):Criteria; a basis for comparison; a reference point against which other things can be evaluated.:Requirement; something that is necessary.","longName":"C87531:C25187:C25466:C38015","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fulfill","conceptCode":"C87531","definition":"Satisfy the requirements or expectations of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Low Density Lipoprotein","conceptCode":"C25187","definition":"A lipoprotein that carries cholesterol around the body, for use by various cells.  LDL transports cholesterol to the arteries and increased levels are associated with atherosclerosis, and thus myocardial infarctions and strokes. This is why cholesterol inside LDL lipoproteins is called bad cholesterol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Requirement","conceptCode":"C38015","definition":"Requirement; something that is necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3DDEADA-71C1-CAA0-E040-BB89AD436E94","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-08-13","modifiedBy":"ONEDATA","dateModified":"2013-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3DDEADA-71D2-CAA0-E040-BB89AD436E94","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"SAFE-HEaRT. LCC. ghd. 08.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"STATIN_LDL_CRIT_REQU_IND","type":"Context Short Name","context":"LCC"},{"name":"STAT_FFL_LDL_CRT_IND","type":"C3D Name","context":"LCC"},{"name":"3854781v1.0:3506068v1.0","type":"USED_BY","context":"LCC"}],"ReferenceDocuments":[{"name":"Start or increase dose of sta","type":"Preferred Question Text","description":"Start or increase dose of statin is needed to meet goal:","url":null,"context":"LCC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3DDFBAA-1BCC-769C-E040-BB89AD4323C7","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-08-13","modifiedBy":"FORMBUILDER","dateModified":"2013-08-16","changeDescription":"SAFE-HEaRT. LCC. ghd. 08.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}